Sun Pharma gets USFDA import ban on Gujarat plant

The United States Food and Drug Administration (USFDA) has imposed an import alert, effectively

RELATED ARTICLES

a ban, on generic drugmaker Sun Pharmaceutical Industries Ltd's plant in Gujarat.

An "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices, according to the FDA website.

A spokesman for Sun, India's biggest drugmaker by market value, was not available for comment.

The plant in Karkhadi in Gujarat makes both drug ingredients and formulations, according to Sun's 2013 annual report.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • India must redefine poverty based on mobile haves and have nots

    Who is poor? Who is not?

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Tushar Gandhi

We’re nothing without our farmers

For centuries, India has been an agrarian and a skill ...

Purnendu Ghosh

Love or hate can happen at sight

Hate, like love, is an all-consuming passion. There are people ...

Shona Adhikari

Taking a leaf out of nature for inspiration

I was on a 10-day visit to Bangalore. ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture